Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to HEALTHCARE ACCESS

Practical Neurology

Addressing the Physician Shortage: Postgraduate Licensure (PGL) for Unmatched Medical School Graduates

Neurology September 12th 2023

Cancer Care Business Exchange (CBEx)

Industry Consolidation: Risant Health, A National Network for Value-Based Care

Oncology, Medical August 7th 2023

Pharmacy Today

Pharmacists Increasing Access to Reproductive Health Care

Clinical Pharmacology June 30th 2023

ACP Internist

Quadruple Therapy for Heart Failure Cost-effective Compared to Previous Standard of Care

Cardiology June 22nd 2023

OBR Oncology

Cross-border ‘Twinning Programs’ May Reduce Survival Disparities for Childhood Leukemia

Hematology/Oncology June 12th 2023

OBR Oncology

Cancer Drug Shortages: Liability Concerns and Fears for Patient Care

Oncologists and cancer drug shortages are creating a crisis, with patient care at risk and legal liabilities looming. In the face of critical cancer drug shortages, oncologists grapple with suboptimal patient care and possible legal liabilities. The issue worsens due to insufficient guidelines for alternative treatment options. A contributing factor is the weak financial incentive for drug manufacturers to produce unprofitable generic drugs, compared to branded ones. Consequently, there’s greater dependence on foreign factories, leading to supply chain hitches and quality control issues. Barbara McAneny, MD, CEO of New Mexico Cancer Center, foresees drug shortages persisting, particularly affecting low-cost treatments. The American Society of Health-System Pharmacists (ASHP) reports shortages of vital oncology drugs like methotrexate, cisplatin, carboplatin, and fluorouracil, crucial for treating various common cancers. Furthermore, the lack of guidelines on alternative treatments exacerbates oncologists’ concerns about patient outcomes and legal liabilities. This absence of direction leaves physicians making crucial decisions single-handedly. In response, the American Society of Clinical Oncology (ASCO) has formed an advisory group to develop clinical guidance during these drug shortages. Immediate recommendations include reprioritizing nonessential use of scarce antineoplastic drugs, increasing interval cycles, reducing doses when clinically acceptable, and selecting evidence-based alternatives. Dr. Jeff Patton, CEO […]

Hematology May 30th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form